4Kishimoto H,Sprent J.The thymus and central tolerance.Clin immunol,2000,95(1 Pt 2):S3
5Deng CS , Goluszko E and Christadoss P. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.J Immunol, 2001, 166(5):3 458
6Wu JM,Wu B,Miagkov et al.Specific immunotherapy of experimental myasthenia gravis in vitro:the ''guided missile''strategy.Cell Immunol, 2001,208(2):137
7Krammer PH,Dhein J,Walacxak H,et al.The role of APO-1 mediated apoptosis in immune system.Immunol Rev,1994,142:175
8Moulian N, Bidault J, Truffault F, et al.Thymocyte Fas Expression Is Dysregulated in Myasthenia Gravis Patients With Anti-Acetylcholine Receptor Antibody. Blood, 1997,89(9):3 287
9Rieux-Laucat F, Deist FL,Hivroz C, et al.Mutation in Fas associated with human lymphoproliferative syndrome and autoimmunity.Science,1995,268(5 215):1 347
10Fisher GH,Rosenberg FJ,Straus SE et al.Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.Cell,1995,81(6):935
